Management and operation of a biocontainment laboratory for infectious disease research
Official title: Facility Management, Maintenance and Operation Core
Funded at University of Missouri-Columbia · NIH-10910191 · Data updated 2026-11-12
This study looks at how the University of Missouri's special lab keeps everyone safe while researching serious infectious diseases, making sure everything runs smoothly and securely so that scientists can do their important work without risks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $734,874 |
| NIH project number | 5UC7AI180306-02 |
| Project ID | NIH-10910191 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include researchers and healthcare professionals involved in infectious disease studies requiring high-level biosafety measures.
✕Less likely to help
Patients who are not involved in infectious disease research or do not require high-level containment for their conditions may not receive any benefit from this research.
What this research studies
This research focuses on the management and operation of the University of Missouri's Regional Biocontainment Laboratory, which is designed to safely conduct research on infectious diseases that require high-level containment. The facility employs strict security measures and a comprehensive maintenance schedule to ensure the safety of laboratory workers and the environment. By maintaining critical building systems and emergency procedures, the lab aims to support ongoing research while minimizing risks associated with handling select agent pathogens.
Why it matters
Potential benefit: If successful, this research could enhance the safety and efficiency of infectious disease research, ultimately leading to better understanding and treatment of communicable diseases.
How similar studies have gone: While the specific management of BSL-3 facilities is a specialized area, similar approaches in biocontainment and infectious disease research have shown success in enhancing safety and research outcomes.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Richardson, Mark D — University of Missouri-Columbia
- Study coordinator: Richardson, Mark D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.